AnaptysBio, Inc. ANAB
46.63 USD -0.77 (-1.62%)
Regular-session close
46.63 0.00 0.00%
After hours · Nov 20, 4:38 PM ET
46.05 Day range 47.66
25.11 52-week range 69.81
- YTD
- +44.28%
- 1 year
- +85.70%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 234.60M | 91.28M | 17.16M | 10.29M | 63.17M | |
| 234.60M | 91.28M | 17.16M | 10.29M | 63.17M | |
| 226.90M | 66.15M | -164.41M | -115.15M | -56.81M | |
| -13.23M | -145.23M | -163.62M | -128.72M | -57.80M | |
| -0.44 | -4.92 | -6.08 | -4.57 | -2.11 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 138.20M | 23.08M | 35.97M | 71.31M | 495.73M | |
| 364.39M | 483.83M | 452.39M | 610.38M | 643.07M | |
| 327.19M | 412.97M | 364.29M | 348.28M | 286.64M | |
| 290.64M | 369.46M | 328.62M | 323.86M | 272.05M | |
| 37.21M | 70.87M | 88.10M | 262.10M | 356.43M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 19.70M | -135.34M | -120.80M | -73.59M | -45.92M | |
| 228.03M | 31.36M | 144.75M | -394.85M | 38.84M | |
| -132.61M | 127.05M | -59.30M | 44.02M | 252.30M | |
| 115.12M | 23.08M | -35.34M | -424.42M | 245.21M |
